-

KBRA Releases Research – Non-QM Redemption Backlog Builds

NEW YORK--(BUSINESS WIRE)--KBRA releases research which discusses how the RMBS market created the conditions for a glut of seasoned Non-QM loans which may reenter the securitization market in the future via redemption activity. We also examine certain factors that have and may continue to forestall such redemptions, such as investor expectations, transaction-level nuances, and current market factors.

Key Takeaways

  • While the redemption of these transactions and the re-securitization of these loans may be deferred over the near term, that delay will only apply to a portion of the increasingly more numerous redeemable loans and may not extend beyond 2023, assuming market conditions stabilize.
  • Further, given low expected prepayment rates over the near term, delays in redemptions will compound the volume of loans eligible to reenter the market down the road, as the 2020 and 2021 securitizations also become eligible for redemption.
  • Past NQM securitizations have been generally called within a year of becoming eligible for redemption, which aligns with senior class investors’ expectations, but extension is more likely without protections from structural mechanisms, such as step-up coupons.
  • The current rising rate environment disincentivizes issuer redemption by reducing the value of existing loans and increasing the required coupon on newly securitized classes.

Click here to view the report.

Related Publications

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Contacts

Chris Deasy, Director
+1 (646) 731-1311
chris.deasy@kbra.com

Daniel Hall, Director
+1 (646) 731-2421
daniel.hall@kbra.com

Armine Karajyan, Senior Director
+1 (646) 731-1210
armine.karajyan@kbra.com

Jack Kahan, Senior Managing Director
+1 (646) 731-2486
jack.kahan@kbra.com

Business Development Contact

Daniel Stallone, Senior Director
+1 (646) 731-1308
daniel.stallone@kbra.com

KBRA

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Contacts

Chris Deasy, Director
+1 (646) 731-1311
chris.deasy@kbra.com

Daniel Hall, Director
+1 (646) 731-2421
daniel.hall@kbra.com

Armine Karajyan, Senior Director
+1 (646) 731-1210
armine.karajyan@kbra.com

Jack Kahan, Senior Managing Director
+1 (646) 731-2486
jack.kahan@kbra.com

Business Development Contact

Daniel Stallone, Senior Director
+1 (646) 731-1308
daniel.stallone@kbra.com

More News From KBRA

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom